In conclusion, FGFR4 is involved in the proliferation of HCC cells by ERK/CUL3/cyclin E signaling pathway and these findings may provide a potential theoretical basis for treatment by targeting FGFR4 in HCC (Fig 5). This evidence concerns the gene FGFR4 and hepatocellular carcinoma.